Earnings calendar/IBRX
ImmunityBio, Inc. (IBRX)
Pre-earnings consensus targets and post-earnings beat/miss — standardized metrics from the earnings calendar. No narrative, no price targets.
Pre-earnings
Consensus targets for the next print, plus how the business has been running.
Next report
Nov 3, 2026
Consensus estimate row
EPS target
$-0.08
Street estimate
Revenue target
$59.2M
Street estimate
Trailing EPS (avg 4Q)
$-0.24
Beat rate last 4: 50%
Latest EPS YoY
-120.0%
vs 2025-08-05
Latest revenue YoY
+93.9%
How results look so far
Trailing revenue (avg 4Q)
$41.4M
Printed quarters
EPS beat rate (4Q)
50%
Share of quarters that beat EPS est.
Post-earnings
Did the company hit the target? Actual vs estimate and surprise.
Last print
Aug 4, 2026
EPS miss
EPS actual / est
$-0.22 / $-0.08
-175.0%
Revenue actual / est
$51.2M / $49.7M
+3.1%
Result
Below target
Based on EPS vs consensus
Earnings history
Estimate vs actual and surprise % by print date
| Date | EPS est | EPS act | EPS surprise | Rev est | Rev act | Rev surprise |
|---|---|---|---|---|---|---|
| 11/3/2026upcoming | $-0.08 | Pending | — | $59.2M | Pending | — |
| 8/4/2026 | $-0.08 | $-0.22 | -175.0% | $49.7M | $51.2M | +3.1% |
| 5/11/2026upcoming | $-0.08 | Pending | — | $43.1M | Pending | — |
| 5/7/2026 | $-0.08 | $-0.62 | -675.0% | $43.1M | $44.2M | +2.6% |
| 3/2/2026upcoming | $-0.08 | Pending | — | — | Pending | — |
| 2/23/2026 | $-0.08 | $-0.06 | +25.0% | $38.4M | $38.3M | -0.2% |
| 11/4/2025 | $-0.10 | $-0.07 | +30.0% | $37.8M | $32.1M | -15.1% |
| 8/5/2025 | $-0.10 | $-0.10 | 0.0% | $31.9M | $26.4M | -17.1% |
| 5/12/2025 | $-0.12 | $-0.15 | -25.0% | $16.6M | $16.5M | -0.5% |
| 3/3/2025 | $-0.26 | $-0.09 | +65.4% | $9.6M | $7.6M | -21.5% |
| 11/12/2024 | $-0.18 | $-0.14 | +22.2% | $9.1M | $6.1M | -32.7% |
| 8/12/2024 | $-0.17 | $-0.20 | -17.6% | $2.5M | $1.0M | -58.5% |
| 5/9/2024 | $-0.16 | $-0.20 | -25.0% | $20,000 | $40,000 | +100.0% |
| 3/19/2024 | $-0.18 | $-0.36 | -100.0% | $25,000 | $119,500 | +378.0% |
| 11/8/2023 | $-0.27 | $-0.19 | +29.6% | $20,000 | $82,000 | +310.0% |
| 8/8/2023 | $-0.26 | $-0.28 | -7.7% | $360,000 | $41,000 | -88.6% |
| 5/11/2023 | $-0.27 | $-0.27 | 0.0% | $360,000 | $360,000 | 0.0% |
| 3/1/2023 | $-0.22 | $-0.27 | -22.7% | $25,000 | $73,000 | +192.0% |
| 11/9/2022 | $-0.23 | $-0.28 | -21.7% | $118,000 | $118,000 | 0.0% |
| 8/8/2022 | $-0.24 | $-0.24 | 0.0% | $25,000 | $35,000 | +40.0% |
| 5/10/2022 | $-0.22 | $-0.26 | -18.2% | $25,000 | $14,000 | -44.0% |
| 3/2/2022 | $-0.21 | $-0.23 | -9.5% | $25,000 | $390,000 | +1460.0% |
| 11/12/2021 | $-0.20 | $-0.22 | -10.0% | $20,000 | $66,000 | +230.0% |
| 8/12/2021 | $-0.12 | $-0.23 | -91.7% | $235,968.19 | $339,000 | +43.7% |
| 5/14/2021 | $-0.41 | $-0.21 | +48.8% | $186,124 | $139,000 | -25.3% |
| 3/4/2021 | $-0.18 | $-0.30 | -66.7% | — | $147,000 | — |
| 11/9/2020 | $-0.18 | $-0.20 | -11.1% | — | $151,000 | — |
| 8/7/2020 | $-0.19 | $-0.20 | -5.3% | — | $436,000 | — |
| 5/11/2020 | $-0.17 | $-0.19 | -11.8% | — | $165,000 | — |
| 3/25/2020 | $-0.20 | $-0.16 | +20.0% | — | $920,000 | — |
| 11/5/2019 | $-0.18 | $-0.16 | +11.1% | — | $12,000 | — |
| 8/6/2019 | $-0.24 | $-0.17 | +29.2% | — | $17,000 | — |
| 5/8/2019 | $-0.23 | $-0.22 | +4.3% | — | $5,000 | — |
| 3/13/2019 | $-0.31 | $-0.22 | +29.0% | — | $7,000 | — |
| 11/7/2018 | $-0.37 | $-0.30 | +18.9% | — | $31,000 | — |
| 8/6/2018 | $-0.38 | $-0.35 | +7.9% | — | $4,000 | — |
| 5/7/2018 | $-0.34 | $-0.35 | -2.9% | — | $5,000 | — |
| 3/12/2018 | $-0.33 | $-0.31 | +6.1% | — | $12,000 | — |
| 11/7/2017 | $-0.32 | $-0.30 | +6.3% | — | $8,000 | — |
| 8/7/2017 | $-0.31 | $-0.29 | +6.5% | — | $14,000 | — |
| 5/8/2017 | $-0.36 | $-0.30 | +16.7% | — | $11,000 | — |
| 3/15/2017 | $-0.43 | $-0.29 | +32.6% | — | $14,000 | — |
| 11/10/2016 | $-0.45 | $-0.39 | +13.3% | — | $12,000 | — |
| 8/15/2016 | $-0.58 | $-0.41 | +29.3% | — | $12,000 | — |
| 5/16/2016 | $-0.37 | $-0.38 | -2.7% | — | $6,000 | — |
| 3/30/2016 | $-0.23 | $-0.97 | -321.7% | — | $14,000 | — |
| 11/12/2015 | $-0.10 | $-0.55 | -450.0% | — | $10,000 | — |
| 9/10/2015 | $-0.13 | $-1.29 | -892.3% | — | $91,000 | — |
Need IBRX data in your own agent or pipeline?
The earnings data on this page — report dates, consensus EPS/revenue estimates, actuals and surprise history — is also available programmatically through the EvidInvest MCP server & financial data API for Claude, Cursor, or any MCP client and HTTP pipeline.